Global Longlife Hospital and R (GLHRL.BO)
INR 21.5
(0.0%)
INR 21.5
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 135.18 Million | 235.05 Million | 328.36 Million | 327.02 Million | 335.44 Million | 345.4 Million |
| Cost of Revenue | 118.73 Million | 172.21 Million | 214.77 Million | 249.88 Million | 93.3 Million | 96.26 Million |
| Gross Profit | 16.44 Million | 62.84 Million | 113.59 Million | 77.13 Million | 242.13 Million | 249.13 Million |
| Operating Expenses | 127 Thousand | 33.82 Million | 43.45 Million | 37.34 Million | 229.7 Million | 203.61 Million |
| Selling, General and Administrative Expenses | 127 Thousand | 278 Thousand | 750 Thousand | - | 1.86 Million | 4.8 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 118.86 Million | 206.03 Million | 258.22 Million | 287.23 Million | 323.01 Million | 299.87 Million |
| Operating Income | 16.32 Million | 29.04 Million | 71.75 Million | 41.32 Million | 12.62 Million | 46.26 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 778 Thousand | 8.8 Million | 21.36 Million | 2.89 Million | 2.02 Million | 13.22 Million |
| Earnings before Tax | -22.65 Million | 27.07 Million | 57.1 Million | 17.57 Million | -10.64 Million | 26.87 Million |
| Net Income | -21.88 Million | 18.27 Million | 35.73 Million | 20.46 Million | -8.62 Million | 13.64 Million |
| Earnings Per Share Basic | -2.08 | 1.79 | 5.11 | 2.92 | -1.23 | 2.53 |
| Earnings Per Share Diluted | -2.08 | 1.79 | 5.11 | 2.92 | -1.23 | 2.53 |
| Weighted Average Shares Outstanding | 10.5 Million | 10.2 Million | 7 Million | 7.01 Million | 7 Million | 5.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.5 Million | 10.18 Million | 7 Million | 7 Million | 7 Million | 5.38 Million |
| Gross Margin | 0.12 | 0.27 | 0.35 | 0.24 | 0.72 | 0.72 |
| EBIT Margin | -0.02 | 0.17 | 0.25 | 0.17 | 0.08 | 0.18 |
| Profit Margin | -0.16 | 0.08 | 0.11 | 0.06 | -0.03 | 0.04 |
| EBITDA | -2.43 Million | 40.71 Million | 83.18 Million | 54.37 Million | 27.95 Million | 61.79 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.22 | 0.13 | 0.04 | 0.13 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 5.94 Million | 135.14 Million | 5.92 Million | 61.65 Million | 61.65 Million | 235.05 Million |
| Cost of Revenue | 18.43 Million | 118.01 Million | 18.07 Million | 40.92 Million | 40.92 Million | 172.21 Million |
| Gross Profit | -12.49 Million | 17.12 Million | -12.15 Million | 20.72 Million | 20.72 Million | 62.84 Million |
| Operating Expenses | 63.5 Thousand | 32.1 Million | 5.9 Million | 10.14 Million | 10.14 Million | 33.82 Million |
| Selling, General and Administrative Expenses | 63.5 Thousand | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 18.5 Million | 150.12 Million | 23.98 Million | 51.07 Million | 51.07 Million | 206.03 Million |
| Operating Income | -12.56 Million | -15.6 Million | -18.27 Million | 10.46 Million | 10.46 Million | 29.04 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.79 Million | 778 Thousand | 3.79 Million | 3.4 Million | 3.4 Million | 8.8 Million |
| Earnings before Tax | -19.87 Million | -22.65 Million | -19.87 Million | 8.54 Million | 8.54 Million | 27.07 Million |
| Net Income | -16.08 Million | -21.88 Million | -16.08 Million | 5.14 Million | 5.14 Million | 18.27 Million |
| Earnings Per Share Basic | -1.53 | - | -1.53 | 0.49 | 0.49 | - |
| Earnings Per Share Diluted | -1.53 | - | -1.53 | 0.49 | 0.49 | - |
| Weighted Average Shares Outstanding | 10.49 Million | 10.51 Million | 10.53 Million | 10.5 Million | 10.5 Million | 10.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.49 Million | 10.51 Million | 10.53 Million | 10.5 Million | 10.5 Million | 10.18 Million |
| Gross Margin | -2.10 | 0.13 | -2.05 | 0.34 | 0.34 | 0.27 |
| EBIT Margin | -2.48 | - | -2.55 | 0.22 | 0.22 | - |
| Profit Margin | -2.71 | -0.16 | -2.72 | 0.08 | 0.08 | 0.08 |
| EBITDA | -14.75 Million | - | -15.09 Million | 13.54 Million | 13.54 Million | - |
| Earnings Before Tax Margin | -2.11 | -0.12 | -3.09 | 0.17 | 0.17 | 0.12 |
TSLX
4350
SVNTF
GLYC
TMIP
BITE